Inovio Pharmaceuticals Stock Discussion

$Inovio Pharmaceuticals (INO.US)$ Reuters· 1 min ago
New Retrospective Data Shows Half of Rrp Patients Treated With Ino-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

$Inovio Pharmaceuticals (INO.US)$ Reuters· 1 min ago
Inovio Announces New Data at Scientific Conferences for Lead Candidate, Ino-3107, as a Potential Treatment for Rrp

$Inovio Pharmaceuticals (INO.US)$ $iBio Inc (IBIO.US)$
On Friday, the fear of human-to-human spread grew ever so slightly: The CDC confirmed that four health-care workers in Missouri had fallen sick after caring for a patient who was infected with bird flu.

$iBio Inc (IBIO.US)$ $Inovio Pharmaceuticals (INO.US)$ Bird flu is growing
https://www.msn.com/en-us/health/other/bird-flu-pandemic-fears-skyrocket-as-us-identifies-first-cases-of-possible-human-to-human-transmission/ar-AA1rwhf5?ocid=BingNewsSerp

$Inovio Pharmaceuticals (INO.US)$ Reuters· 3 mins ago
Inovio Receives Advanced Therapy Medicinal Product Certificate From European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate Ino-3107

$Inovio Pharmaceuticals (INO.US)$ Pretty chart! I guess nobody with me? Hehehe

$Inovio Pharmaceuticals (INO.US)$ Company Announced That INO-3107, Has Been Designated an Innovative Medicine as Part of the U.K.'s Innovative Licensing and Access Pathway

$Inovio Pharmaceuticals (INO.US)$ INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
 • BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
 • Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
 • Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...

$Inovio Pharmaceuticals (INO.US)$ Inovio Pharmaceuticals Inc - Pricing of an Underwritten Offering of 2.5 Mln Shares of Its Common Stock at an Offering Price of $7.693 per Share